Medtronic Enters Bone Pact with OsteoGenix

Minneapolis, MN-based Medtronic Inc. said its spine business, located in Memphis, TN, entered a development agreement with privately held OsteoGenix Inc. Founded in 2005 in Palo Alto, CA, OsteoGenix is a therapeutic products company developing novel products for accelerating bone repair and bone growth.

Financial details were not disclosed.

Under the agreement, OsteoGenix will complete work on preclinical trials for its proprietary bone anabolic agent, which is intended to grow new bone, and continue development into clinical trials. Medtronic said it would receive another source of bone growth therapies as part of the agreement.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters